PT1183035E - Transplante de medula óssea para tratamento de acidente vascular cerebral - Google Patents

Transplante de medula óssea para tratamento de acidente vascular cerebral Download PDF

Info

Publication number
PT1183035E
PT1183035E PT00935910T PT00935910T PT1183035E PT 1183035 E PT1183035 E PT 1183035E PT 00935910 T PT00935910 T PT 00935910T PT 00935910 T PT00935910 T PT 00935910T PT 1183035 E PT1183035 E PT 1183035E
Authority
PT
Portugal
Prior art keywords
stroke
treatment
bone marrow
marrow transplantation
transplantation
Prior art date
Application number
PT00935910T
Other languages
English (en)
Original Assignee
Ford Henry Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ford Henry Health System filed Critical Ford Henry Health System
Publication of PT1183035E publication Critical patent/PT1183035E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
PT00935910T 1999-05-14 2000-05-11 Transplante de medula óssea para tratamento de acidente vascular cerebral PT1183035E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13434499P 1999-05-14 1999-05-14

Publications (1)

Publication Number Publication Date
PT1183035E true PT1183035E (pt) 2015-03-04

Family

ID=22462927

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00935910T PT1183035E (pt) 1999-05-14 2000-05-11 Transplante de medula óssea para tratamento de acidente vascular cerebral

Country Status (9)

Country Link
US (1) US20090162327A1 (pt)
EP (1) EP1183035B1 (pt)
JP (1) JP2002544234A (pt)
AU (1) AU780994B2 (pt)
CA (1) CA2373808C (pt)
DK (1) DK1183035T3 (pt)
ES (1) ES2531592T3 (pt)
PT (1) PT1183035E (pt)
WO (1) WO2000069448A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
US8017112B2 (en) 1999-05-14 2011-09-13 Henry Ford Health System Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases
US20050169896A1 (en) * 1999-05-14 2005-08-04 Henry Ford Health System Bone marrow transplantation for treatment of stroke
US6749850B1 (en) 1999-08-18 2004-06-15 The General Hospital Corporation Methods, compositions and kits for promoting recovery from damage to the central nervous system
MXPA02001719A (es) * 1999-08-18 2003-09-25 Childrens Medical Center METODOS, COMPOSICIONES Y EQUIPOS PARA PROMOVER LA RECUPERACION DEL DAnO AL SISTEMA NERVIOSO CENTRAL.
US20010038836A1 (en) * 2000-04-04 2001-11-08 Matthew During Application of myeloid-origin cells to the nervous system
AU2001274624A1 (en) 2000-06-26 2002-01-08 Renomedix Institute Inc. Cell fraction containing cells capable of differentiating into nervous system cells
ES2180433B1 (es) * 2001-05-28 2004-05-16 Universidad Miguel Hernandez De Elche. Empleo de celulas madre hematopoyeticas en la generacion de celulas madre neurales.
US9969980B2 (en) 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
WO2003038075A1 (fr) * 2001-10-30 2003-05-08 Renomedix Institute Inc. Procede permettant d'induire une differenciation de cellules souches embroyonnaires mesodermiques, de cellules es ou de cellules immortalisees dans des cellules du systeme nerveux
EP1469852A4 (en) * 2002-01-04 2009-12-02 Ford Henry Health System DONORS OF NITROGEN MONOXIDE FOR THE TREATMENT OF DISEASES AND INJURIES
WO2003060082A2 (en) 2002-01-14 2003-07-24 The Board Of Trustees Of The University Of Illinois Use of modified pyrimidine compounds to promote stem cell migration and proliferation
US9969977B2 (en) 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
US20060210544A1 (en) 2003-06-27 2006-09-21 Renomedix Institute, Inc. Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient
WO2005007176A1 (ja) * 2003-06-27 2005-01-27 Renomedix Institute Inc. 間葉系細胞を有効成分とする体内投与用脳神経疾患治療薬
US20080107632A1 (en) * 2006-09-06 2008-05-08 Henrich Cheng Fibrin glue composition for repairing nerve damage and methods thereof
KR20100035648A (ko) 2007-06-15 2010-04-05 가넷 바이오쎄라퓨틱스 인크. 체외 배양 및 증식 자기재생성 집락 형성 세포를 이용한 질환 및 장애 치료방법
JP5276816B2 (ja) * 2007-09-10 2013-08-28 肇 井上 神経機能改善剤
KR20110010694A (ko) * 2008-02-28 2011-02-07 헨리 포드 헬쓰 시스템 중추신경계 손상의 치료를 향상시키기 위해 기질 세포를 이용하는 조성물 및 방법
JP6156889B2 (ja) 2013-02-06 2017-07-05 Ｎｃメディカルリサーチ株式会社 神経変性の治療のための不均質な骨髄細胞の亜集団を調製する方法
EP3354725B1 (en) * 2013-10-14 2019-12-04 Hadasit Medical Research Services and Development Ltd. Terminally differentiated neuronal lineages and uses thereof
JPWO2015174087A1 (ja) * 2014-05-16 2017-04-20 公益財団法人先端医療振興財団 脳梗塞の予防及び／又は治療の為の医薬
RU2612981C1 (ru) * 2015-12-21 2017-03-14 Алексей Сергеевич Бывальцев Способ лечения ишемического инсульта
US11464804B1 (en) 2017-11-15 2022-10-11 Enrico Stazzone Intrathecal multifactorial infusion of heterogeneous autologous cell therapy

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666828A (en) * 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) * 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) * 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) * 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) * 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5612211A (en) * 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
US5750376A (en) * 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US5851832A (en) * 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
DE69429721T2 (de) * 1993-04-13 2002-09-05 Us Gov Health & Human Serv Verwendung von neuronalen fötalen zellinien für transplantationstherapie
US6653134B2 (en) * 1995-03-28 2003-11-25 Cp Hahnemann University Isolated stromal cells for use in the treatment of diseases of the central nervous system
AU3888699A (en) * 1998-05-07 1999-11-23 University Of South Florida Bone marrow cells as a source of neurons for brain and spinal cord repair
GB9904281D0 (en) * 1999-02-24 1999-04-21 Reneuron Ltd Transplantation

Also Published As

Publication number Publication date
DK1183035T3 (en) 2015-03-09
CA2373808C (en) 2011-04-19
AU5130000A (en) 2000-12-05
ES2531592T3 (es) 2015-03-17
WO2000069448A1 (en) 2000-11-23
JP2002544234A (ja) 2002-12-24
EP1183035B1 (en) 2014-12-03
US20090162327A1 (en) 2009-06-25
EP1183035A1 (en) 2002-03-06
CA2373808A1 (en) 2000-11-23
AU780994B2 (en) 2005-04-28
EP1183035A4 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
EP1183035A4 (en) BONE MARK TRANSPLANTATION FOR TREATING A STROKE
IL160923A0 (en) Bone fixation system
AU2002331798A1 (en) Multi-lineage directed induction of bone marrow stromal cell differentiation
AU2000257674A1 (en) Bone marrow biopsy needle
DE59907286D1 (de) Marknagel zur Knochendistraktion
PT1066838E (pt) Composição para a regeneração de tecidos ósseos
AU2002353044A8 (en) System and method for bone fixation
AU2001259154A1 (en) Bone fixation system
HK1027986A1 (en) Method of sterilization
HUP0202853A3 (en) Use of retigabin for treating neuropathic pain
GB2355051B (en) Strain-inducing conical screw for stimulating bone transplant growth
ZA995980B (en) Reduction forceps for long bone fractures.
GB9920785D0 (en) Bone splint
EP1150684A4 (en) BONE CEMENT ANTI-RESORPTION AND ALLOGENOUS BONE IMPLANTS, AUTOGRAFTS AND XENOGRAFTS
AU3904200A (en) Bone fracture fixation clip
GB9928837D0 (en) Novel bone cement
AU6245898A (en) Injectable formulations for treatment of osteoporotic bone
EP1513404A4 (en) INTRAMYOCARDIAL INJECTIONS OF AUTOLOGOUS BONE MARROW
IL132078A0 (en) Bone marrow as a site for transplantation
HUP0001890A2 (en) Tissue structure for transplantation surgery
AU2002364941A8 (en) Engineered bone marrow
IL143990A0 (en) Bone stimulating factor
GB9906257D0 (en) An improved bone marrow biopsy needle
GB0130539D0 (en) Bone marrow-specific protein
IL142480A0 (en) Tissue growth stimulating system